CTMX
CytomX Therapeutics Inc.
$2.06
+$0.08(+4.04%)
66
Overall
60
Value
72
Tech
--
Quality
Market Cap
$326.53M
Volume
3.01M
52W Range
$0.40 - $3.10
Target Price
$5.75
Key Metrics Overview
| Market Cap | $326.53M | P/E Ratio | 29.43 |
| 52W High | $3.10 | 52W Low | $0.40 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 31.9% | 52W Position | 61.6% |
| Overall Score | 66 | Value Score | 60 |
| Quality Score | -- | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $0.07 | EPS Next Est | $-0.3 |
| EPS Growth Est | -528.6% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $2.06 | +4.0% | 3.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW